Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Male Breast Cancer Access Plan to the Hereditary Cancer Program
FY 2019-20
Summary
"The British Columbia (BC) Hereditary Cancer Program (HCP) is responsible for testing variation in cancer genes within individuals. Focuses of this service include assessing the risk of inheriting cancer causing genes, predicting the disease progression, and identifying the best personalized treatment plans. In male breast cancer (MBC), commonly characterized genes can be found in both the germline cells which are reproductive, and somatic cells that make up the rest. All MBC patients in BC have access to be genetically tested through the HCP. However, there is still a large proportion of patients who are not referred to this publicly funded service due to a lack of awareness. This is a missed opportunity for providing cancer risk assessments to families, patient access to drug trials, and collecting information for future research. This would advance the overall success of reducing MBC mortality. The Male Breast Cancer Access Plan to the Hereditary Cancer Program (MAP to the HCP) is a trial for tumour sequencing with the inclusion of deceased and living patients, and then implementing a reflex referral. I will investigate tumour sequencing in somatic tumour cells, and compare this procedure with current HCP practice. Current standard entails blood sequencing that detects only germline cell mutations. Evaluation of both procedures by comparing differences in the detected gene variants will be performed A reflex referral process works by automatically referring new MBC diagnosis patients to the HCP at the time they are diagnosed, decreasing the missed cases. Results gathered from this study will be applied to other cancers that are genetic tested at the HCP and will have important consequences to manage all cancer risk and treatments. "
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
428750
Name
Chan Laura L
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Male Breast Cancer Access Plan to the Hereditary Cancer Program
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer Prevention; Cancer Treatment; Clinical Genetics; Gene Panels; Hereditary Cancer Risk; Male Breast Cancer; Oncology; Personalized Medicine; Reflex Referral; Tumour Sequencing
Abstract
"The British Columbia (BC) Hereditary Cancer Program (HCP) is responsible for testing variation in cancer genes within individuals. Focuses of this service include assessing the risk of inheriting cancer causing genes, predicting the disease progression, and identifying the best personalized treatment plans. In male breast cancer (MBC), commonly characterized genes can be found in both the germline cells which are reproductive, and somatic cells that make up the rest. All MBC patients in BC have access to be genetically tested through the HCP. However, there is still a large proportion of patients who are not referred to this publicly funded service due to a lack of awareness. This is a missed opportunity for providing cancer risk assessments to families, patient access to drug trials, and collecting information for future research. This would advance the overall success of reducing MBC mortality. The Male Breast Cancer Access Plan to the Hereditary Cancer Program (MAP to the HCP) is a trial for tumour sequencing with the inclusion of deceased and living patients, and then implementing a reflex referral. I will investigate tumour sequencing in somatic tumour cells, and compare this procedure with current HCP practice. Current standard entails blood sequencing that detects only germline cell mutations. Evaluation of both procedures by comparing differences in the detected gene variants will be performed A reflex referral process works by automatically referring new MBC diagnosis patients to the HCP at the time they are diagnosed, decreasing the missed cases. Results gathered from this study will be applied to other cancers that are genetic tested at the HCP and will have important consequences to manage all cancer risk and treatments. "
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chan, Laura L
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~